Literature DB >> 33553025

Relationship of angiotensin converting enzyme (I/D) polymorphism (rs4646994) and coronary heart disease among a male Iraqi population with type 2 diabetes mellitus.

Raghda N Hemeed1, Fadhil J Al-Tu'ma1, Dhafer A F Al-Koofee2, Ahmed H Al-Mayali3.   

Abstract

BACKGROUND: Insertion deletion (I/D) polymorphism (rs4646994) in the angiotensin-converting enzyme (ACE) has a substantial effect on coronary heart disease (CHD). The amplification of an Alu repetitive element in an intron of the ACE has shown three potential genotypes of I/I and D/D as homozygous, and I/D as heterozygous.
OBJECTIVE: The objective of this study was to investigate the association between the ACE gene polymorphism and CHD among male Iraqi patients with and without type2 diabetes mellitus (T2DM).
METHODS: A case-control study of total 217 male subjects participated in this study, divided into three groups; Group 1 including 86 CHD patients with T2DM, group 2 including 78 CHD patients without T2DM, and group 3 including 53 age and sex-matched healthy individuals (as a control group). Genotyping of ACE (I/D) gene was performed using polymerase chain reaction (PCR) technique.
RESULTS: The II allele was significantly more frequent in CHD patients without T2DM compared to the control population, but not from those patients with T2DM (p < 0.05). Nonetheless, the ID allele was significantly more frequent in each of CHD with T2DM and control populations compared to the CHD without T2DM. The DD allele was significantly more frequent in CHD patients with T2DM compared to each of CHD patients without T2DM and control populations (p < 0.05).
CONCLUSION: We conclude that the D/D and I/D genotypes are implicated as risk factors for development of CHD with T2DM, but not CHD without T2DM among the male Iraqi population. However, larger sample sizes are needed to monitor the CHD patients and to validate this study. © Springer Nature Switzerland AG 2020.

Entities:  

Keywords:  Angiotensin converting enzyme; Coronary heart disease; Ischemic heart disease; Type 2 Diabetes Mellitus

Year:  2020        PMID: 33553025      PMCID: PMC7843895          DOI: 10.1007/s40200-020-00632-y

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  22 in total

Review 1.  Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications.

Authors:  Bernard J Gersh; Karen Sliwa; Bongani M Mayosi; Salim Yusuf
Journal:  Eur Heart J       Date:  2010-02-22       Impact factor: 29.983

Review 2.  Atherosclerotic Cardiovascular Disease in South Asians in the United States: Epidemiology, Risk Factors, and Treatments: A Scientific Statement From the American Heart Association.

Authors:  Annabelle Santos Volgman; Latha S Palaniappan; Neelum T Aggarwal; Milan Gupta; Abha Khandelwal; Aruna V Krishnan; Judith H Lichtman; Laxmi S Mehta; Hena N Patel; Kevin S Shah; Svati H Shah; Karol E Watson
Journal:  Circulation       Date:  2018-05-24       Impact factor: 29.690

Review 3.  The role of coronary artery disease in heart failure.

Authors:  Anuradha Lala; Akshay S Desai
Journal:  Heart Fail Clin       Date:  2014-04       Impact factor: 3.179

4.  The Effect of ACE I/D Polymorphisms Alone and With Concomitant Risk Factors on Coronary Artery Disease.

Authors:  Ahmed Amara; Meriem Mrad; Aicha Sayeh; Dhaker Lahideb; Samy Layouni; Abdeddayem Haggui; Najiba Fekih-Mrissa; Habib Haouala; Brahim Nsiri
Journal:  Clin Appl Thromb Hemost       Date:  2016-11-28       Impact factor: 2.389

5.  Relation of mitral annular calcium and coronary calcium (from the Multi-Ethnic Study of Atherosclerosis [MESA]).

Authors:  Yasmin S Hamirani; Khurram Nasir; Roger S Blumenthal; Junichiro Takasu; David Shavelle; Richard Kronmal; Matthew Budoff
Journal:  Am J Cardiol       Date:  2011-02-23       Impact factor: 2.778

6.  Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia.

Authors:  Roberto Ferrari; Carlos Aguiar; Eduardo Alegria; Riccardo C Bonadonna; Francesco Cosentino; Moses Elisaf; Michel Farnier; Jean Ferrières; Pasquale Perrone Filardi; Nicolae Hancu; Meral Kayikcioglu; Alberto Mello E Silva; Jesus Millan; Željko Reiner; Lale Tokgozoglu; Paul Valensi; Margus Viigimaa; Michal Vrablik; Alberto Zambon; José Luis Zamorano; Alberico L Catapano
Journal:  Eur Heart J Suppl       Date:  2016-04-12       Impact factor: 1.803

Review 7.  New insights into the regulation of HDL metabolism and reverse cholesterol transport.

Authors:  Gary F Lewis; Daniel J Rader
Journal:  Circ Res       Date:  2005-06-24       Impact factor: 17.367

8.  Angiotensin converting enzyme I/D, angiotensinogen T174M-M235T and angiotensin II type 1 receptor A1166C gene polymorphisms in Turkish hypertensive patients.

Authors:  Bedia Agachan; Turgay Isbir; Hulya Yilmaz; Emel Akoglu
Journal:  Exp Mol Med       Date:  2003-12-31       Impact factor: 8.718

9.  Angiotensin converting enzyme DD genotype is associated with acute coronary syndrome severity and sudden cardiac death in Taiwan: a case-control emergency room study.

Authors:  Ying-Hsin Chen; Jui-Ming Liu; Ren-Jun Hsu; Sheng-Chuan Hu; Horng-Jyh Harn; Shee-Ping Chen; Jing-Ren Jeng; Chieh-Lin Wu; Jar-Yi Ho; Cheng-Ping Yu
Journal:  BMC Cardiovasc Disord       Date:  2012-02-15       Impact factor: 2.298

10.  Use of Outpatient Cardiac Rehabilitation Among Heart Attack Survivors - 20 States and the District of Columbia, 2013 and Four States, 2015.

Authors:  Jing Fang; Carma Ayala; Cecily Luncheon; Matthew Ritchey; Fleetwood Loustalot
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-08-25       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.